These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 240449)

  • 1. Pharmacotherapy in early infantile autism.
    Campbell M
    Biol Psychiatry; 1975 Aug; 10(4):399-423. PubMed ID: 240449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Review of psychopharmacological treatments in adolescents and adults with autistic disorders].
    Baghdadli A; Gonnier V; Aussilloux C
    Encephale; 2002; 28(3 Pt 1):248-54. PubMed ID: 12091786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risperidone: new indication. Behavioural disorders in children with autism or mental disabilities: no progress.
    Prescrire Int; 2006 Apr; 15(82):43-5. PubMed ID: 16602211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety issues with drug therapies for autism spectrum disorders.
    McCracken JT
    J Clin Psychiatry; 2005; 66 Suppl 10():32-7. PubMed ID: 16401148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychopharmacology in childhood disorders.
    Wiener JM
    Psychiatr Clin North Am; 1984 Dec; 7(4):831-43. PubMed ID: 6151651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of atypical antipsychotics in the treatment of autistic disorder.
    Stachnik JM; Nunn-Thompson C
    Ann Pharmacother; 2007 Apr; 41(4):626-34. PubMed ID: 17389666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacotherapy of irritability in pervasive developmental disorders.
    Stigler KA; McDougle CJ
    Child Adolesc Psychiatr Clin N Am; 2008 Oct; 17(4):739-52, vii-viii. PubMed ID: 18775367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyproheptadine in the treatment of autistic disorder: a double-blind placebo-controlled trial.
    Akhondzadeh S; Erfani S; Mohammadi MR; Tehrani-Doost M; Amini H; Gudarzi SS; Yasamy MT
    J Clin Pharm Ther; 2004 Apr; 29(2):145-50. PubMed ID: 15068403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modeling clinical outcome of children with autistic spectrum disorders.
    Coplan J; Jawad AF
    Pediatrics; 2005 Jul; 116(1):117-22. PubMed ID: 15995041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacologic treatment for the core deficits and associated symptoms of autism in children.
    West L; Waldrop J; Brunssen S
    J Pediatr Health Care; 2009; 23(2):75-89. PubMed ID: 19232924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mood-stabilizing drugs in depression.
    Shelton RC
    J Clin Psychiatry; 1999; 60 Suppl 5():37-40; discussion 41-2. PubMed ID: 10192406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacologic treatment of behavioral symptoms in autism and pervasive developmental disorders.
    Findling RL
    J Clin Psychiatry; 2005; 66 Suppl 10():26-31. PubMed ID: 16401147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antipsychotic treatment in childhood and adolescence: a bibliographical review].
    García López MM
    Actas Esp Psiquiatr; 2001; 29(1):41-6. PubMed ID: 11333518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tianeptine: a novel strategy of psychopharmacological treatment of children with autistic disorder.
    Niederhofer H; Staffen W; Mair A
    Hum Psychopharmacol; 2003 Jul; 18(5):389-93. PubMed ID: 12858327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of risperidone in children with autism spectrum disorder.
    Chavez B; Chavez-Brown M; Rey JA
    Ann Pharmacother; 2006 May; 40(5):909-16. PubMed ID: 16684811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Research Units on Pediatric Psychopharmacology (RUPP) Autism Network. Background and rationale for an initial controlled study of risperidone.
    McDougle CJ; Scahill L; McCracken JT; Aman MG; Tierney E; Arnold LE; Freeman BJ; Martin A; McGough JJ; Cronin P; Posey DJ; Riddle MA; Ritz L; Swiezy NB; Vitiello B; Volkmar FR; Votolato NA; Walson P
    Child Adolesc Psychiatr Clin N Am; 2000 Jan; 9(1):201-24. PubMed ID: 10674197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmaco-therapeutic evaluation of medical treatments of adult autistics and multi-handicapped patients in a public mental health unit].
    Armand-Branger S; Poisson N; Gaudoneix-Taïeb M; Ramos O
    Encephale; 2009 Sep; 35(4):370-6. PubMed ID: 19748374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Psychopharmacology of autism].
    Chabrol H; Bonnet D; Roge B
    Encephale; 1996; 22(3):197-203. PubMed ID: 8767048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of antipsychotic medication in child and adolescent psychiatric treatment in Denmark. A cross-sectional survey.
    Deurell M; Weischer M; Pagsberg AK; Labianca J
    Nord J Psychiatry; 2008; 62(6):472-80. PubMed ID: 18841508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risperidone use in the treatment of behavioral symptoms in children with autism.
    West L; Waldrop J
    Pediatr Nurs; 2006; 32(6):545-9. PubMed ID: 17256292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.